Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.